| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/2011 | US20110008848 Enzyme |
| 01/13/2011 | US20110008844 Sialyltransferase and dna encoding the same |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008841 Polynucleotides encoding il-17 receptor a antigen binding proteins |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008839 Expression Vectors Comprising the MCMV IE2 Promoter |
| 01/13/2011 | US20110008836 Method for producing alpha-santalene |
| 01/13/2011 | US20110008834 Polynucleotides encoding antibodies directed against amyloid-beta peptide |
| 01/13/2011 | US20110008832 Methods for stably retaining foreign genes in cells |
| 01/13/2011 | US20110008829 Use of Synthetic Scaffolds for the Production of Biosynthetic Pathway Products |
| 01/13/2011 | US20110008828 Methods of incorporating amino acid analogs into proteins |
| 01/13/2011 | US20110008812 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 01/13/2011 | US20110008808 Biomarkers |
| 01/13/2011 | US20110008793 Maize Polymorphisms and Methods of Genotyping |
| 01/13/2011 | US20110008792 Promoters for expression in modified vaccinia virus ankara |
| 01/13/2011 | US20110008782 Site-specific incorporation of redox active amino acids into proteins |
| 01/13/2011 | US20110008781 Isothermal amplification of nucleic acids on a solid support |
| 01/13/2011 | US20110008778 Method of Generating p° Cells |
| 01/13/2011 | US20110008774 Protein discovery using intracellular ribosome display |
| 01/13/2011 | US20110008770 Compositions and methods for reverse transcription of nucleic acid molecules |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008523 Genetic sequences having methyltransferase activity and uses therefor |
| 01/13/2011 | US20110008520 Soybean variety a1015971 |
| 01/13/2011 | US20110008519 Soybean variety a1016467 |
| 01/13/2011 | US20110008518 Soybean variety a1015901 |
| 01/13/2011 | US20110008517 Soybean variety a1016522 |
| 01/13/2011 | US20110008513 Soybean variety a1016136 |
| 01/13/2011 | US20110008512 Soybean variety a1016109 |
| 01/13/2011 | US20110008511 Soybean variety a1015669 |
| 01/13/2011 | US20110008510 Soybean variety a1016242 |
| 01/13/2011 | US20110008509 Soybean variety a1016189 |
| 01/13/2011 | US20110008451 Compositions and methods for controlled delivery of inhibitory ribonucleic acids |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008358 Human monoclonal antibodies that specifically bind igf-ii |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008355 Anti-flt3 antibodies |
| 01/13/2011 | US20110008353 Identification of astrovirus va1 associated with gastroenteritis in humans |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008350 Extracellular targets for alzheimer's disease |
| 01/13/2011 | US20110008348 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 01/13/2011 | US20110008344 Fusion partner cell line for preparation of hybrid cells expressing human antibodies |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008339 Monoclonal antibody and use thereof |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008321 Vectors, Host Cells, and Methods of Production and Uses |
| 01/13/2011 | US20110008319 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
| 01/13/2011 | US20110008318 Toll-like receptor 5 ligands and methods of use |
| 01/13/2011 | US20110008315 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
| 01/13/2011 | US20110008292 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 01/13/2011 | US20110008283 Interferon fusion proteins |
| 01/13/2011 | US20110008249 Proteins with high immunoreactivity and method for their production |
| 01/13/2011 | US20110005697 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 01/13/2011 | DE112008002456T5 Pflanzen mit erhöhtem Ertrag Plants with increased yield |
| 01/13/2011 | DE102005047717B4 Ribonukleasen mit Adenosin-Spezifität Ribonucleases with adenosine specificity |
| 01/13/2011 | CA2805403A1 Bioengineered silk protein-based nucleic acid delivery systems |
| 01/13/2011 | CA2804602A1 Codon-optimized factor viii variants and synthetic liver-specific promoter |
| 01/13/2011 | CA2781595A1 Compositions and methods for diagnosing and treating macular degeneration |
| 01/13/2011 | CA2767623A1 Compositions and methods for mammalian genetics and uses thereof |
| 01/13/2011 | CA2767616A1 Gene expression profiles associated with chronic allograft nephropathy |
| 01/13/2011 | CA2767612A1 Variants of plasminogen and plasmin |
| 01/13/2011 | CA2767561A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | CA2767545A1 Method to develop high oleic acid soybeans using conventional soybean breeding techniques |
| 01/13/2011 | CA2767521A1 Detecting multinucleotide repeats |
| 01/13/2011 | CA2767519A1 Method for increasing the resistance of a plant or a part thereof to a pathogen, method for screening the resistance of a plant or part thereof to a pathogen, and use thereof |
| 01/13/2011 | CA2767503A1 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | CA2767491A1 Process for preparation of tacrolimus |
| 01/13/2011 | CA2767490A1 Disruption of ckx3 and at least one other ckx gene in a plant or plant cell leads to improved traits |
| 01/13/2011 | CA2767468A1 Rock2 and rock3, two new gain-of-function variants of the cytokinin receptors ahk2 and ahk3 |
| 01/13/2011 | CA2767442A1 Antibody having anti-cancer activity |
| 01/13/2011 | CA2767438A1 Method for providing fertile plants via induction of bbm during transformation |
| 01/13/2011 | CA2767408A1 Chemically modified ligase cofactors, donors and acceptors |
| 01/13/2011 | CA2767392A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767367A1 The use of two micrornas in lung cancer prognosis and drug preparation |
| 01/13/2011 | CA2767361A1 Engineered microorganisms with enhanced fermentation activity |
| 01/13/2011 | CA2767251A1 Insulin preparations containing methionine |
| 01/13/2011 | CA2767231A1 Cell-based bioprocessing |
| 01/13/2011 | CA2767225A1 Compositions and methods for enhancing production of a biological product |
| 01/13/2011 | CA2767207A1 Bioprocessing |
| 01/13/2011 | CA2767169A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/13/2011 | CA2766996A1 Humanised antibodies to toll-like receptor 2 and uses thereof |
| 01/13/2011 | CA2766858A1 Expression cassettes for endosperm-specific expression in plants |
| 01/13/2011 | CA2766856A1 Detection and visualization of the cell cycle in living cells |
| 01/13/2011 | CA2766608A1 Bi-specific digoxigenin binding antibodies |
| 01/13/2011 | CA2766204A1 Methods and compositions for the recombinant biosynthesis of n-alkanes |
| 01/13/2011 | CA2766166A1 Design of stable and aggregation free antibody fc molecules through ch3 domain interface engineering |
| 01/13/2011 | CA2766123A1 Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene |
| 01/13/2011 | CA2766069A1 Biosynthesis of 1-alkenes in engineered microorganisms |
| 01/13/2011 | CA2765857A1 Method for generating aptamers with improved off-rates |
| 01/13/2011 | CA2765686A1 Plants having modulated carbon partitioning and a method for making the same |
| 01/13/2011 | CA2765504A1 A method for inducing extended self-renewal of functionally differentiated somatic cells |
| 01/13/2011 | CA2765090A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/13/2011 | CA2762524A1 Carbon nanotubes complexed with multiple bioactive agents and methods related thereto |
| 01/12/2011 | EP2273270A1 Method and apparatus for the preparation and/or analysis of biochemical carriers |
| 01/12/2011 | EP2272988A2 Method for detecting human papillomavirus mRNA |